ArticleCancers2026

Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose Reduction.

Shunsuke Tatsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.